Teega-wende C. Ouedraogo

Ouagadougou, Burkina Faso

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Glutathione S-Transferase Mu1 polymorphisms and environmental factors in cervical cancer susceptibility: a systematic review and meta-analysis.

Glutathione S-Transferase Mu1 polymorphisms and environmental factors in cervical cancer susceptibility: a systematic review and meta-analysis.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)

Published: November 07, 2025

Association Between Polymorphisms rs11003125 and rs7096206 of the MBL2 Gene and the Stages of Hepatitis B Progression in Burkina Faso: A Comparative Cross-Sectional Study.

Association Between Polymorphisms rs11003125 and rs7096206 of the MBL2 Gene and the Stages of Hepatitis B Progression in Burkina Faso: A Comparative Cross-Sectional Study.

Journal: Health science reports

Published: April 22, 2025

The Frequency of CYP2C19*2 Gene Polymorphisms in Burkina Faso Patients Treated with Clopidogrel.

The Frequency of CYP2C19*2 Gene Polymorphisms in Burkina Faso Patients Treated with Clopidogrel.

Journal: The application of clinical genetics

Published: December 06, 2024

Polymorphisms rs2074292 of the MAP3K14 Gene and rs1883832 of the CD40 Gene and Breast Cancer in Women in Burkina Faso: A Case-Control Study.

Polymorphisms rs2074292 of the MAP3K14 Gene and rs1883832 of the CD40 Gene and Breast Cancer in Women in Burkina Faso: A Case-Control Study.

Journal: Health science reports

Published: October 01, 2024

High Frequency of CYP2C19*3 Heterozygotes Among Patients Under Clopidogrel Treatment in Ouagadougou, Burkina Faso.

High Frequency of CYP2C19*3 Heterozygotes Among Patients Under Clopidogrel Treatment in Ouagadougou, Burkina Faso.

Journal: Pakistan journal of biological sciences : PJBS

Published: September 20, 2024

Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso.

Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso.

Journal: Open life sciences

Published: June 22, 2023

Association of HLA-DRB111 and HLA-DRB112 gene polymorphism with COVID-19 in Burkina Faso.

Association of HLA-DRB111 and HLA-DRB112 gene polymorphism with COVID-19 in Burkina Faso.

Journal: BMC medical genomics

Published: April 13, 2023

Molecular epidemiology of human papillomavirus in pregnant women in Burkina Faso.

Molecular epidemiology of human papillomavirus in pregnant women in Burkina Faso.

Journal: Biomolecular concepts

Published: November 20, 2022

Involvement of ERCC1 (rs3212986) and ERCC2 (rs1799793, rs13181) polymorphisms of DNA repair genes in breast cancer occurrence in Burkina Faso.

Involvement of ERCC1 (rs3212986) and ERCC2 (rs1799793, rs13181) polymorphisms of DNA repair genes in breast cancer occurrence in Burkina Faso.

Journal: Molecular genetics & genomic medicine

Published: May 25, 2022

Carriage of Ser217Leu and Ala541Thr Variants of ELAC2 Gene and Risk Factors in Patients with Prostate Cancer in Burkina Faso.

Carriage of Ser217Leu and Ala541Thr Variants of ELAC2 Gene and Risk Factors in Patients with Prostate Cancer in Burkina Faso.

Journal: Prostate cancer

Published: May 12, 2022

Carriage of mutations R462Q (rs 486907) and D541E (rs 627928) of the RNASEL gene and risk factors in patients with prostate cancer in Burkina Faso.

Carriage of mutations R462Q (rs 486907) and D541E (rs 627928) of the RNASEL gene and risk factors in patients with prostate cancer in Burkina Faso.

Journal: BMC medical genomics

Published: November 01, 2021

Molecular characterization of high-risk human papillomavirus (HR-HPV) in women in Lomé, Togo.

Molecular characterization of high-risk human papillomavirus (HR-HPV) in women in Lomé, Togo.

Journal: BMC infectious diseases

Published: August 11, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026